Lividomycin
Appearance
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C29H55N5O19 |
Molar mass | 777.775 g·mol−1 |
3D model (JSmol) | |
| |
|
Lividomycin is a broad-spectrum aminoglycoside antibiotic.[1] It is effective against most Gram-positive and Gram-negative bacteria including Mycobacterium tuberculosis (the causative agent of tuberculosis) and Pseudomonas aeruginosa.[2]
References
[edit]- ^ Kobayashi F, Yamaguchi M, Mitsuhashi S (January 1972). "Activity of lividomycin against Pseudomonas aeruginosa: its inactivation by phosphorylation induced by resistant strains". Antimicrobial Agents and Chemotherapy. 1 (1): 17–21. doi:10.1128/AAC.1.1.17. PMC 444159. PMID 4207755.
- ^ Kobayashi F, Nagoya T, Yoshimura Y, Kaneko K, Ogata SI (February 1972). "Studies on New Antibiotic Lividomycins. V In vitro and in vivo antimicrobial activity of lividomycin A". The Journal of Antibiotics. 25 (2): 128–136. doi:10.7164/antibiotics.25.128. PMID 4624613.